Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Pilger A et al. | 2004 | intact cell/cell culture, human diploid fibroblast cells | magnetic field, low frequency, 50/60 Hz | 1 mT |
Craviso GL et al. | 2003 | intact cell/cell culture, bovine adrenal medullary chromaffin cells | 50/60 Hz, magnetic field | 10 µT–2 mT |
Madec F et al. | 2003 | murine islets of Langerhans, mouse/OF1 | magnetic field, low frequency, 50/60 Hz, static magnetic field | 20.7 µT–1 mT |
Craviso GL et al. | 2002 | intact cell/cell culture, chromaffin cells (from bovine adrenal medullas) | magnetic field, 50/60 Hz | 10 µT–2 mT |
Obo M et al. | 2002 | intact cell/cell culture, PC-12D cells (subline of the PC-12 cell line, derived from pheochromocytoma cells from the rat adrenal medulla) | magnetic field, static magnetic field, 50/60 Hz | 14.8–150 µT |
McCreary CR et al. | 2002 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, static magnetic field, 50/60 Hz, co-exposure | 78–100 µT |
Mattsson MO et al. | 2001 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) from three different sources | magnetic field, 50/60 Hz, static magnetic field, shielding/field deprivation | 150 µT |
Pessina GP et al. | 2001 | intact cell/cell culture, U-373 MG (human astrocytoma cell line) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 3 mT |
Aldinucci C et al. | 2000 | intact cell/cell culture, U-373 MG (human astrocytoma cell line) | magnetic field, signals/pulses, 50/60 Hz | 3 mT |
Wey HE et al. | 2000 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz | 150 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.